Literature DB >> 18582451

Role of polyunsaturated fatty acids in the management of Egyptian children with autism.

Nagwa A Meguid1, Hazem M Atta, Amr S Gouda, Rehab O Khalil.   

Abstract

OBJECTIVE: Estimation of free polyunsaturated fatty acids (PUFAs) in blood and evaluation of behavior of autistic children before and after taking fish oil (Efalex) were performed. DESIGN AND METHODS: 30 autistic children (18 males and 12 females) aged 3-11 years and 30 healthy children as control group were included in this study. Tandem mass spectrometry and CARS were used to estimate the free PUFAs from dried blood spot and to evaluate the autistic behavior respectively.
RESULTS: Before taking Efalex, linolenic acid showed a significant reduction (71%), followed by docosahexaenoic acid (65%) and arachidonic acid (45%), while linoleic acid was the least affected PUFA (32%). After taking Efalex, 66% of autistic children showed clinical and biochemical improvement, linolenic acid and docosahexaenoic acid showed the highest levels after Efalex supplementation.
CONCLUSION: PUFA supplementation may play an important role in ameliorating the autistic behavior.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18582451     DOI: 10.1016/j.clinbiochem.2008.05.013

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  27 in total

Review 1.  Improving the prediction of response to therapy in autism.

Authors:  Stephen Bent; Robert L Hendren
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 2.  The potential relevance of docosahexaenoic acid and eicosapentaenoic acid to the etiopathogenesis of childhood neuropsychiatric disorders.

Authors:  Alessandra Tesei; Alessandro Crippa; Silvia Busti Ceccarelli; Maddalena Mauri; Massimo Molteni; Carlo Agostoni; Maria Nobile
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-12-17       Impact factor: 4.785

Review 3.  Brain carnitine deficiency causes nonsyndromic autism with an extreme male bias: A hypothesis.

Authors:  Arthur L Beaudet
Journal:  Bioessays       Date:  2017-07-13       Impact factor: 4.345

4.  ω-3 and ω-6 Fatty Acid Supplementation May Reduce Autism Symptoms Based on Parent Report in Preterm Toddlers.

Authors:  Sarah A Keim; Barbara Gracious; Kelly M Boone; Mark A Klebanoff; Lynette K Rogers; Joseph Rausch; Daniel L Coury; Kelly W Sheppard; Jesse Husk; Dale A Rhoda
Journal:  J Nutr       Date:  2018-02-01       Impact factor: 4.798

5.  Micronutrients versus standard medication management in autism: a naturalistic case-control study.

Authors:  Lewis Mehl-Madrona; Brenda Leung; Carla Kennedy; Sarah Paul; Bonnie J Kaplan
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-04       Impact factor: 2.576

Review 6.  Omega-3 fatty acids for autistic spectrum disorder: a systematic review.

Authors:  Stephen Bent; Kiah Bertoglio; Robert L Hendren
Journal:  J Autism Dev Disord       Date:  2009-03-31

7.  Nutritional and Metabolic Biomarkers in Autism Spectrum Disorders: An Exploratory Study.

Authors:  Anna E Esparham; Teri Smith; John M Belmont; Michael Haden; Leigh E Wagner; Randall G Evans; Jeanne A Drisko
Journal:  Integr Med (Encinitas)       Date:  2015-04

8.  The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders.

Authors:  Raymond H Thomas; Melissa M Meeking; Jennifer R Mepham; Lisa Tichenoff; Fred Possmayer; Suya Liu; Derrick F MacFabe
Journal:  J Neuroinflammation       Date:  2012-07-02       Impact factor: 8.322

9.  A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder.

Authors:  Stephen Bent; Kiah Bertoglio; Paul Ashwood; Alan Bostrom; Robert L Hendren
Journal:  J Autism Dev Disord       Date:  2011-05

10.  A review of complementary and alternative treatments for autism spectrum disorders.

Authors:  Nicholas Lofthouse; Robert Hendren; Elizabeth Hurt; L Eugene Arnold; Eric Butter
Journal:  Autism Res Treat       Date:  2012-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.